Kinase Inhibitors in Cancer Therapy: A Look Ahead

ISSN： 0012-6667

Source： Drugs, Vol.59, Iss.3, 2000-03, pp. : 435-476

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New RAF kinase inhibitors in cancer therapy

By Martin-Liberal Juan Larkin James

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 9, 2014-06 ,pp. : 1235-1245

Informa Healthcare

Access to resources Recommend Favorite

Development of RET Kinase Inhibitors for Targeted Cancer Therapy

Current Medicinal Chemistry, Vol. 18, Iss. 2, 2011-01 ,pp. : 162-175

Bentham Science Publishers

Access to resources Recommend Favorite

Phase I/II RAF kinase inhibitors in cancer therapy

By Turajlic Samra Ali Zohra Yousaf Nadia Larkin James

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 739-749

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Tyrosine Kinase Inhibitors: The New Dawn for Cancer Therapy

Letters in Drug Design & Discovery, Vol. 9, Iss. 1, 2012-01 ,pp. : 84-125

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents

Current Medicinal Chemistry, Vol. 22, Iss. 2, 2014-12 ,pp. : 237-263

Bentham Science Publishers

Access to resources Recommend Favorite